{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:38:40Z","timestamp":1791639520714,"version":"4.3.4"},"reference-count":201,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T00:00:00Z","timestamp":1595808000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005075","name":"Universitair Medisch Centrum Groningen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005075","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Virology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.coviro.2020.07.009","type":"journal-article","created":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T19:39:09Z","timestamp":1597174749000},"page":"9-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":128,"special_numbering":"C","title":["Recent advances in antiviral drug development towards dengue virus"],"prefix":"10.1016","volume":"43","author":[{"given":"Berit","family":"Troost","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanda M","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coviro.2020.07.009_sbref0005","series-title":"Advances in Experimental Medicine and Biology","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/978-981-10-8727-1_22","article-title":"Dengue antiviral development: a continuing journey","author":"Low","year":"2018"},{"key":"10.1016\/j.coviro.2020.07.009_bib0010","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.cell.2015.07.005","article-title":"Molecular insight into dengue virus pathogenesis and its implications for disease control","volume":"162","author":"Diamond","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.coviro.2020.07.009_bib0015","doi-asserted-by":"crossref","first-page":"20718","DOI":"10.2807\/1560-7917.ES2014.19.8.20718","article-title":"The 2012 dengue outbreak in Madeira: exploring the origins","volume":"19","author":"Wilder-Smith","year":"2014","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.coviro.2020.07.009_bib0020","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJMoa1506223","article-title":"Efficacy and long-term safety of a dengue vaccine in regions of endemic disease","volume":"373","author":"Hadinegoro","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coviro.2020.07.009_bib0025","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.4269\/ajtmh.2005.73.1063","article-title":"Differences in dengue severity in infants, children, and adults in a 3-year hospital-based study in Nicaragua","volume":"73","author":"Hammond","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.coviro.2020.07.009_sbref0030","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.coviro.2016.09.003","article-title":"The quest for host targets to combat dengue virus infections","volume":"20","author":"Acosta","year":"2016","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.coviro.2020.07.009_bib0035","first-page":"745","article-title":"New insights into the immunopathology and control of dengue virus infection","volume":"15","author":"Screaton","year":"2015","journal-title":"Nat Publ Gr"},{"key":"10.1016\/j.coviro.2020.07.009_bib0040","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.190009","article-title":"Role of autophagy during the replication and pathogenesis of common mosquito-borne flavi- and alphaviruses","volume":"9","author":"Echavarria-Consuegra","year":"2019","journal-title":"Open Biol"},{"key":"10.1016\/j.coviro.2020.07.009_bib0045","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nrd.2017.33","article-title":"Broad-spectrum agents for flaviviral infections: dengue, zika and beyond","volume":"16","author":"Boldescu","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.coviro.2020.07.009_sbref0050","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.antiviral.2018.12.016","article-title":"Dengue drug discovery: progress, challenges and outlook","volume":"163","author":"Lim","year":"2019","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2020.07.009_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coph.2016.06.002","article-title":"Towards antiviral therapies for treating dengue virus infections","volume":"30","author":"Kaptein","year":"2016","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.coviro.2020.07.009_bib0060","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.2217\/fmb.15.105","article-title":"Dengue: an update on treatment options","volume":"10","author":"Chan","year":"2015","journal-title":"Future Microbiol"},{"key":"10.1016\/j.coviro.2020.07.009_sbref0065","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2741\/4630","article-title":"Drug repurposing approaches to fight dengue virus infection and related diseases","volume":"23","author":"Botta","year":"2018","journal-title":"Front Biosci Landmark"},{"key":"10.1016\/j.coviro.2020.07.009_sbref0070","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrd.2017.162","article-title":"Host-directed therapies for bacterial and viral infections","volume":"17","author":"Kaufmann","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.coviro.2020.07.009_bib0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002627","article-title":"Small-molecule inhibitors of dengue-virus entry","volume":"8","author":"Schmidt","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2020.07.009_bib0080","doi-asserted-by":"crossref","first-page":"719","DOI":"10.7150\/ijms.5037","article-title":"Inhibition of dengue virus entry into target cells using synthetic antiviral peptides","volume":"10","author":"Alhoot","year":"2013","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.coviro.2020.07.009_bib0085","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10867-018-9515-6","article-title":"Dynamics and binding interactions of peptide inhibitors of dengue virus entry","volume":"45","author":"Isa","year":"2019","journal-title":"J Biol Phys"},{"key":"10.1016\/j.coviro.2020.07.009_bib0090","doi-asserted-by":"crossref","first-page":"e2188","DOI":"10.1371\/journal.pntd.0002188","article-title":"Sulfated polysaccharide, curdlan sulfate, efficiently prevents entry\/fusion and restricts antibody-dependent enhancement of dengue virus infection in vitro: a possible candidate for clinical application","volume":"7","author":"Ichiyama","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.coviro.2020.07.009_bib0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000721","article-title":"Structural optimization and de novo design of dengue virus entry inhibitory peptides","volume":"4","author":"Costin","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.coviro.2020.07.009_bib0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-422X-2-49","article-title":"Peptide inhibitors of dengue virus and West Nile virus infectivity","volume":"2","author":"Hrobowski","year":"2005","journal-title":"Virol J"},{"key":"10.1016\/j.coviro.2020.07.009_bib0105","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1128\/AAC.01148-08","article-title":"A small-molecule dengue virus entry inhibitor","volume":"53","author":"Wang","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coviro.2020.07.009_bib0110","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.antiviral.2009.09.007","article-title":"In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses","volume":"84","author":"Kampmann","year":"2009","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2020.07.009_bib0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0000428","article-title":"Combinatorial computational approaches to identify tetracycline derivatives as flavivirus inhibitors","volume":"2","author":"Yang","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.coviro.2020.07.009_bib0120","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.antiviral.2009.09.011","article-title":"A small molecule fusion inhibitor of dengue virus","volume":"84","author":"Poh","year":"2009","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2020.07.009_bib0125","doi-asserted-by":"crossref","first-page":"12549","DOI":"10.1128\/JVI.01440-10","article-title":"Peptide inhibitors of flavivirus entry derived from the E protein stem","volume":"84","author":"Schmidt","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.07.009_bib0130","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1021\/cb800176t","article-title":"Antiviral compounds discovered by virtual screening of small-molecule libraries against dengue virus E protein","volume":"3","author":"Zhou","year":"2008","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.coviro.2020.07.009_bib0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021658","article-title":"Broad antiviral activity of carbohydrate-binding agents against the four serotypes of dengue virus in monocyte-derived dendritic cells","volume":"6","author":"Alen","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.coviro.2020.07.009_bib0140","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.bbrc.2008.08.100","article-title":"Structure and anti-dengue virus activity of sulfated polysaccharide from a marine alga","volume":"376","author":"Hidari","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.coviro.2020.07.009_bib0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074035","article-title":"Sulfated Escherichia coli K5 polysaccharide derivatives inhibit dengue virus infection of human microvascular endothelial cells by interacting with the viral envelope protein E domain III","volume":"8","author":"Vervaeke","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.coviro.2020.07.009_bib0150","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.antiviral.2010.09.002","article-title":"Antiviral activity of chondroitin sulphate E targeting dengue virus envelope protein","volume":"88","author":"Kato","year":"2010","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2020.07.009_bib0155","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.antiviral.2005.08.006","article-title":"Antiviral effect of the heparan sulfate mimetic, PI-88, against dengue and encephalitic flaviviruses","volume":"69","author":"Lee","year":"2006","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2020.07.009_bib0160","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/cbdd.12576","article-title":"A peptide inhibitor derived from the conserved ectodomain region of DENV membrane (M) protein with activity against dengue virus infection","volume":"86","author":"Panya","year":"2015","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.coviro.2020.07.009_sbref0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2019.104636","article-title":"A novel flavivirus entry inhibitor, BP34610, discovered through high-throughput screening with dengue reporter viruses","volume":"172","author":"Yang","year":"2019","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2020.07.009_bib0170","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1128\/AAC.01429-12","article-title":"A novel inhibitor of dengue virus replication that targets the capsid protein","volume":"57","author":"Byrd","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coviro.2020.07.009_bib0175","doi-asserted-by":"crossref","first-page":"11540","DOI":"10.1128\/JVI.01745-14","article-title":"Characterization of the mode of action of a potent dengue virus capsid inhibitor","volume":"88","author":"Scaturro","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.07.009_bib0180","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.antiviral.2018.04.019","article-title":"Characterization and structure-activity relationship analysis of a class of antiviral compounds that directly bind dengue virus capsid protein and are incorporated into virions","volume":"155","author":"Smith","year":"2018","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2020.07.009_bib0185","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1021\/cb500640t","article-title":"Understanding dengue virus capsid protein disordered N-terminus and pep14-23-based inhibition","volume":"10","author":"Faustino","year":"2015","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.coviro.2020.07.009_bib0190","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1086\/511310","article-title":"A dengue fever viremia model in mice shows reduction in viral replication and suppression of the inflammatory response after treatment with antiviral drugs","volume":"195","author":"Schul","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2020.07.009_bib0195","doi-asserted-by":"crossref","first-page":"3944","DOI":"10.1128\/AAC.48.10.3944-3953.2004","article-title":"A 7-deaza-adenosine analog is a potent and selective inhibitor of hepatitis C virus replication with excellent pharmacokinetic properties","volume":"48","author":"Olsen","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coviro.2020.07.009_bib0200","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1128\/AAC.01335-10","article-title":"INX-08189, a phosphoramidate prodrug of 6-O-methyl-2\u2032-C-methyl guanosine, is a potent inhibitor of hepatitis C virus replication with excellent pharmacokinetic and pharmacodynamic properties","volume":"55","author":"Vernachio","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coviro.2020.07.009_bib0205","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1128\/JVI.02841-13","article-title":"Activation of peripheral blood mononuclear cells by dengue virus infection depotentiates balapiravir","volume":"88","author":"Chen","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.07.009_bib0210","doi-asserted-by":"crossref","first-page":"6123","DOI":"10.1016\/j.bmc.2012.08.021","article-title":"Synthesis and antiviral activity of 4,6-disubstituted pyrimido[4,5-b]indole ribonucleosides","volume":"20","author":"Tich\u00fd","year":"2012","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.coviro.2020.07.009_bib0215","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1016\/j.bmc.2013.05.052","article-title":"Functionalized hydroxyethylamine based peptide nanostructures as potential inhibitors of falcipain-3, an essential proteases of Plasmodium falciparum","volume":"21","author":"Rathi","year":"2013","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.coviro.2020.07.009_bib0220","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nature13027","article-title":"Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430","volume":"508","author":"Warren","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2020.07.009_bib0225","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/infdis\/jis470","article-title":"A randomized, double-blind placebo controlled trial of balapiravir, a polymerase inhibitor, in adult dengue patients","volume":"207","author":"Nguyen","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2020.07.009_bib0230","doi-asserted-by":"crossref","first-page":"20435","DOI":"10.1073\/pnas.0907010106","article-title":"An adenosine nucleoside inhibitor of dengue virus","volume":"106","author":"Yin","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2020.07.009_bib0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2015.01.002","article-title":"Characterization of the activity of 2\u2032-C-methylcytidine against dengue virus replication","volume":"116","author":"Lee","year":"2015","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2020.07.009_bib0240","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1128\/AAC.00397-10","article-title":"Inhibition of dengue virus by an ester prodrug of an adenosine analog","volume":"54","author":"Chen","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coviro.2020.07.009_bib0245","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1021\/acs.jmedchem.5b00327","article-title":"5\u2032-silylated 3\u2032-1,2,3-triazolyl thymidine analogues as inhibitors of West Nile virus and dengue virus","volume":"58","author":"Vernekar","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.coviro.2020.07.009_bib0250","doi-asserted-by":"crossref","first-page":"6233","DOI":"10.1074\/jbc.M110.179184","article-title":"Small molecule inhibitors that selectively block dengue virus methyltransferase","volume":"286","author":"Lim","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coviro.2020.07.009_bib0255","doi-asserted-by":"crossref","first-page":"8730","DOI":"10.1128\/JVI.00384-12","article-title":"Identification of a novel antiviral inhibitor of the flavivirus guanylyltransferase enzyme","volume":"86","author":"Stahla-Beek","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.07.009_bib0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0130083","article-title":"Murine efficacy and pharmacokinetic evaluation of the flaviviral NS5 capping enzyme 2-thioxothiazolidin-4-one inhibitor BG-323","volume":"10","author":"Bullard","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.coviro.2020.07.009_bib0265","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1021\/acsinfecdis.5b00070","article-title":"Identification and characterization of novel broad-spectrum inhibitors of the flavivirus methyltransferase","volume":"1","author":"Brecher","year":"2016","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.coviro.2020.07.009_bib0270","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.bbrc.2014.09.113","article-title":"Suramin inhibits helicase activity of NS3 protein of dengue virus in a fluorescence-based high throughput assay format","volume":"453","author":"Basavannacharya","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.coviro.2020.07.009_bib0275","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1128\/AAC.02251-12","article-title":"Novel benzoxazole inhibitor of dengue virus replication that targets the NS3 helicase","volume":"57","author":"Byrd","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coviro.2020.07.009_bib0280","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1021\/id5000458","article-title":"Benzothiazole and pyrrolone flavivirus inhibitors targeting the viral helicase","volume":"109","author":"Sweeney","year":"2015","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.coviro.2020.07.009_bib0285","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.antiviral.2012.08.006","article-title":"Fluorescent primuline derivatives inhibit hepatitis C virus NS3-catalyzed RNA unwinding, peptide hydrolysis and viral replicase formation","volume":"96","author":"Ndjomou","year":"2012","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2020.07.009_bib0290","doi-asserted-by":"crossref","first-page":"85938","DOI":"10.1039\/C5RA14469H","article-title":"Reaching beyond HIV\/HCV: nelfinavir as a potential starting point for broad-spectrum protease inhibitors against dengue and chikungunya virus","volume":"5","author":"Bhakat","year":"2015","journal-title":"RSC Adv"},{"key":"10.1016\/j.coviro.2020.07.009_bib0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/psc.3196","article-title":"Carnosine exhibits significant antiviral activity against dengue and zika virus","volume":"25","author":"Rothan","year":"2019","journal-title":"J Pept Sci"},{"key":"10.1016\/j.coviro.2020.07.009_bib0300","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s00705-010-0702-4","article-title":"Identification of palmatine as an inhibitor of West Nile virus","volume":"155","author":"Jia","year":"2010","journal-title":"Arch Virol"},{"key":"10.1016\/j.coviro.2020.07.009_bib0305","doi-asserted-by":"crossref","first-page":"8389","DOI":"10.1021\/jm400828u","article-title":"Thiazolidinone-peptide hybrids as dengue virus protease inhibitors with antiviral activity in cell culture","volume":"56","author":"Nitsche","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.coviro.2020.07.009_bib0310","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1016\/j.bmc.2011.05.015","article-title":"Synthesis and biological evaluation of \u03b1-ketoamides as inhibitors of the dengue virus protease with antiviral activity in cell-culture","volume":"19","author":"Steuer","year":"2011","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.coviro.2020.07.009_bib0315","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ab.2009.08.013","article-title":"A fluorescence quenching assay to discriminate between specific and nonspecific inhibitors of dengue virus protease","volume":"395","author":"Bodenreider","year":"2009","journal-title":"Anal Biochem"},{"key":"10.1016\/j.coviro.2020.07.009_bib0320","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3851\/IMP1767","article-title":"Small molecule pan-dengue and West Nile virus NS3 protease inhibitors","volume":"21","author":"Cregar-Hernandez","year":"2011","journal-title":"Antiviral Chem Chemother"},{"key":"10.1016\/j.coviro.2020.07.009_bib0325","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.antiviral.2009.02.190","article-title":"Structure-based discovery of dengue virus protease inhibitors","volume":"82","author":"Tomlinson","year":"2009","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2020.07.009_bib0330","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.bmc.2012.10.058","article-title":"Design, synthesis and characterization of novel 1,2-benzisothiazol-3(2H)- one and 1,3,4-oxadiazole hybrid derivatives: potent inhibitors of dengue and West Nile virus NS2B\/NS3 proteases","volume":"21","author":"Lai","year":"2013","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.coviro.2020.07.009_bib0335","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.antiviral.2015.03.014","article-title":"The flavivirus NS2B-NS3 protease-helicase as a target for antiviral drug development","volume":"118","author":"Luo","year":"2015","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2020.07.009_bib0340","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.antiviral.2016.08.014","article-title":"High-throughput screening for the identification of small-molecule inhibitors of the flaviviral protease","volume":"134","author":"Balasubramanian","year":"2016","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2020.07.009_bib0345","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1128\/AAC.03543-14","article-title":"Novel dengue virus NS2B\/NS3 protease inhibitors","volume":"59","author":"Wu","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coviro.2020.07.009_bib0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2180-14-140","article-title":"Identification of natural antimicrobial agents to treat dengue infection: in vitro analysis of latarcin peptide activity against dengue virus","volume":"14","author":"Rothan","year":"2014","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.coviro.2020.07.009_bib0355","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1128\/AAC.01281-13","article-title":"A novel dengue virus inhibitor, BP13944, discovered by high-throughput screening with dengue virus replicon cells selects for resistance in the viral NS2B\/NS3 protease","volume":"58","author":"Yang","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coviro.2020.07.009_bib0360","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1128\/AAC.00855-10","article-title":"Novel dengue virus-specific NS2B\/NS3 protease inhibitor, BP2109, discovered by a high-throughput screening assay","volume":"55","author":"Yang","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coviro.2020.07.009_bib0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2334-12-314","article-title":"Inhibition of dengue NS2B-NS3 protease and viral replication in vero cells by recombinant retrocyclin-1","volume":"12","author":"Rothan","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.coviro.2020.07.009_bib0370","article-title":"A small molecule inhibitor of dengue virus type 2 protease inhibits the replication of all four dengue virus serotypes in cell culture","volume":"1","author":"Raut","year":"2015","journal-title":"Virol J"},{"key":"10.1016\/j.coviro.2020.07.009_bib0375","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/aps.2015.56","article-title":"Policresulen, a novel NS2B\/NS3 protease inhibitor, effectively inhibits the replication of DENV2 virus in BHK-21 cells","volume":"36","author":"Wu","year":"2015","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.coviro.2020.07.009_bib0380","doi-asserted-by":"crossref","first-page":"7719","DOI":"10.1021\/acs.jmedchem.5b00612","article-title":"Phenylalanine and phenylglycine analogues as arginine mimetics in dengue protease inhibitors","volume":"58","author":"Weigel","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.coviro.2020.07.009_bib0385","doi-asserted-by":"crossref","first-page":"9354","DOI":"10.1021\/acs.jmedchem.5b01441","article-title":"Discovery of nanomolar dengue and West Nile virus protease inhibitors containing a 4-benzyloxyphenylglycine residue","volume":"58","author":"Behnam","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.coviro.2020.07.009_bib0390","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/cbdd.12500","article-title":"Structure-guided discovery of a novel non-peptide inhibitor of dengue virus NS2B-NS3 protease","volume":"86","author":"Li","year":"2015","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.coviro.2020.07.009_bib0395","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.bbrc.2013.09.078","article-title":"A small compound targeting the interaction between nonstructural proteins 2B and 3 inhibits dengue virus replication","volume":"440","author":"Pambudi","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.coviro.2020.07.009_bib0400","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/jac\/dks147","article-title":"Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug","volume":"67","author":"Mastrangelo","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.coviro.2020.07.009_bib0405","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.antiviral.2011.12.003","article-title":"Use of parallel validation high-throughput screens to reduce false positives and identify novel dengue NS2B-NS3 protease inhibitors","volume":"93","author":"Tomlinson","year":"2012","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2020.07.009_bib0410","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1042\/BJ20120150","article-title":"Ivermectin is a specific inhibitor of importin \u03b1\/\u03b2-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus","volume":"443","author":"Wagstaff","year":"2012","journal-title":"Biochem J"},{"key":"10.1016\/j.coviro.2020.07.009_bib0415","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.antiviral.2013.06.002","article-title":"Nuclear localization of dengue virus (DENV) 1-4 non-structural protein 5; protection against all 4 DENV serotypes by the inhibitor ivermectin","volume":"99","author":"Tay","year":"2013","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2020.07.009_bib0420","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.antiviral.2018.05.003","article-title":"Identification of compound-B, a novel anti-dengue virus agent targeting the non-structural protein 4A","volume":"155","author":"Nobori","year":"2018","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2020.07.009_bib0425","doi-asserted-by":"crossref","first-page":"11183","DOI":"10.1128\/JVI.05468-11","article-title":"Inhibition of dengue virus by targeting viral NS4B protein","volume":"85","author":"Xie","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.07.009_bib0430","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.virol.2008.11.003","article-title":"A single-amino acid substitution in West Nile virus 2K peptide between NS4A and NS4B confers resistance to lycorine, a flavivirus inhibitor","volume":"384","author":"Zou","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2020.07.009_bib0435","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1128\/AAC.02462-15","article-title":"Escape mutations in NS4B render dengue virus insensitive to the antiviral activity of the paracetamol metabolite AM404","volume":"60","author":"Van Cleef","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coviro.2020.07.009_bib0440","doi-asserted-by":"crossref","first-page":"8233","DOI":"10.1128\/JVI.00855-15","article-title":"Discovery of dengue virus NS4B inhibitors","volume":"89","author":"Wang","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.07.009_bib0445","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1021\/ml500521r","article-title":"Lead optimization of spiropyrazolopyridones: a new and potent class of dengue virus inhibitors","volume":"6","author":"Zou","year":"2015","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.coviro.2020.07.009_bib0450","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.antiviral.2013.05.011","article-title":"Identification of a new dengue virus inhibitor that targets the viral NS4B protein and restricts genomic RNA replication","volume":"99","author":"van Cleef","year":"2013","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2020.07.009_bib0455","doi-asserted-by":"crossref","first-page":"7367","DOI":"10.1128\/JVI.00632-13","article-title":"The small molecules AZD0530 and dasatinib inhibit dengue virus RNA replication via fyn kinase","volume":"87","author":"de Wispelaere","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.07.009_bib0460","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1016\/j.biomaterials.2014.01.014","article-title":"A multivalent inhibitor of the DC-SIGN dependent uptake of HIV-1 and dengue virus","volume":"35","author":"Varga","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.coviro.2020.07.009_bib0465","doi-asserted-by":"crossref","first-page":"14682","DOI":"10.1073\/pnas.1508095112","article-title":"Virion-associated phosphatidylethanolamine promotes TIM1-mediated infection by ebola, dengue, and West Nile viruses","volume":"112","author":"Richard","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2020.07.009_bib0470","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/imm.12476","article-title":"Dengue virus requires the CC-chemokine receptor CCR5 for replication and infection development","volume":"145","author":"Marques","year":"2015","journal-title":"Immunology"},{"key":"10.1016\/j.coviro.2020.07.009_bib0475","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/infdis\/jiu377","article-title":"Repurposing of prochlorperazine for use against dengue virus infection","volume":"211","author":"Simanjuntak","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2020.07.009_bib0480","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.antiviral.2016.04.014","article-title":"Novel antiviral activity of bromocriptine against dengue virus replication","volume":"131","author":"Kato","year":"2016","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2020.07.009_bib0485","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00365-14","article-title":"Inhibition of dengue virus replication by a class of small-molecule compounds that antagonize dopamine receptor D4 and downstream mitogen-activated protein kinase signaling","volume":"88","author":"Smith","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.07.009_bib0490","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0042-6822(90)90099-D","article-title":"Acidotropic amines inhibit proteolytic processing of flavivirus prM protein","volume":"174","author":"Randolph","year":"1990","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2020.07.009_bib0495","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000785","article-title":"A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults","volume":"4","author":"Tricou","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.coviro.2020.07.009_bib0500","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1089\/vim.2014.0090","article-title":"BAL: antiviral activity of chloroquine against dengue virus type 2 replication in aotus monkeys","volume":"28","author":"Farias","year":"2015","journal-title":"Viral Immunol"},{"key":"10.1016\/j.coviro.2020.07.009_bib0505","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/1348-0421.12154","article-title":"Chloroquine interferes with dengue-2 virus replication in U937 cells","volume":"58","author":"Farias","year":"2014","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.coviro.2020.07.009_bib0510","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/282734","article-title":"Chloroquine inhibits dengue virus type 2 replication in vero cells but not in C6\/36 cells","volume":"2013","author":"Farias","year":"2013","journal-title":"Sci World J"},{"key":"10.1016\/j.coviro.2020.07.009_bib0515","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1080\/14756366.2017.1306521","article-title":"Effects of NS2B-NS3 protease and furin inhibition on West Nile and dengue virus replication","volume":"32","author":"Kouretova","year":"2017","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.coviro.2020.07.009_bib0520","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.antiviral.2017.03.026","article-title":"Luteolin restricts dengue virus replication through inhibition of the proprotein convertase furin","volume":"143","author":"Peng","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2020.07.009_bib0525","doi-asserted-by":"crossref","first-page":"17345","DOI":"10.1073\/pnas.1010811107","article-title":"Dengue virus nonstructural protein 3 redistributes fatty acid synthase to sites of viral replication and increases cellular fatty acid synthesis","volume":"107","author":"Designed Research; N GRSH","year":"2010","journal-title":"Proc Natl Sci U S A"},{"key":"10.1016\/j.coviro.2020.07.009_bib0530","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000632","article-title":"Dengue virus capsid protein usurps lipid droplets for viral particle formation","volume":"5","author":"Samsa","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2020.07.009_bib0535","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-58468-8","article-title":"Evaluation of the antiviral activity of orlistat (tetrahydrolipstatin) against dengue virus, Japanese encephalitis virus, zika virus and chikungunya virus","volume":"10","author":"Hitakarun","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.coviro.2020.07.009_bib0540","doi-asserted-by":"crossref","first-page":"6470","DOI":"10.1128\/JVI.00117-08","article-title":"Cholesterol effectively blocks entry of flavivirus","volume":"82","author":"Lee","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.07.009_bib0545","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.antiviral.2014.07.002","article-title":"Nordihydroguaiaretic acid (NDGA) inhibits replication and viral morphogenesis of dengue virus","volume":"109","author":"Soto-Acosta","year":"2014","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2020.07.009_bib0550","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.antiviral.2011.11.014","article-title":"U18666A, an intra-cellular cholesterol transport inhibitor, inhibits dengue virus entry and replication","volume":"93","author":"Poh","year":"2012","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2020.07.009_bib0555","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.virol.2009.03.025","article-title":"Cholesterol biosynthesis modulation regulates dengue viral replication","volume":"389","author":"Rothwell","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2020.07.009_bib0560","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000321892","article-title":"Statins reduce dengue virus production via decreased virion assembly","volume":"54","author":"Mart\u00ednez-Gutierrez","year":"2011","journal-title":"Intervirology"},{"key":"10.1016\/j.coviro.2020.07.009_bib0565","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1093\/cid\/civ949","article-title":"Lovastatin for the treatment of adult patients with dengue: a randomized, double-blind, placebo-controlled trial","volume":"62","author":"Whitehorn","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coviro.2020.07.009_bib0570","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087412","article-title":"Lovastatin delays infection and increases survival rates in AG129 mice infected with dengue virus serotype 2","volume":"9","author":"Martinez-Gutierrez","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.coviro.2020.07.009_bib0575","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.3892\/mmr.2016.5519","article-title":"The anti-dengue virus properties of statins may be associated with alterations in the cellular antiviral profile expression","volume":"14","author":"Bryan-Marrugo","year":"2016","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.coviro.2020.07.009_bib0580","doi-asserted-by":"crossref","first-page":"5751","DOI":"10.1021\/jf020560c","article-title":"Tomato glycoalkaloids: role in the plant and in the diet","volume":"50","author":"Friedman","year":"2002","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.coviro.2020.07.009_bib0585","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1093\/infdis\/jiu319","article-title":"A nuclear transport inhibitor that modulates the unfolded protein response and provides in vivo protection against lethal dengue virus infection","volume":"210","author":"Fraser","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2020.07.009_bib0590","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1128\/AAC.04177-14","article-title":"The bioactive lipid 4-hydroxyphenyl retinamide inhibits flavivirus replication","volume":"59","author":"Carocci","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coviro.2020.07.009_bib0595","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2016.03.006","article-title":"Novel dengue virus inhibitor 4-HPR activates ATF4 independent of protein kinase R-like endoplasmic reticulum kinase and elevates levels of eIF2\u03b1 phosphorylation in virus infected cells","volume":"130","author":"Fraser","year":"2016","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2020.07.009_bib0600","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.antiviral.2017.02.015","article-title":"AR-12 suppresses dengue virus replication by down-regulation of PI3K\/AKT and GRP78","volume":"142","author":"Chen","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2020.07.009_bib0605","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1371\/journal.pntd.0000086","article-title":"Host gene expression profiling of dengue virus infection in cell lines and patients","volume":"1","author":"Fink","year":"2007","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.coviro.2020.07.009_bib0610","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1128\/JVI.02483-10","article-title":"Appraising the roles of CBLL1 and the ubiquitin\/proteasome system for flavivirus entry and replication","volume":"85","author":"Fernandez-Garcia","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.07.009_bib0615","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004058","article-title":"Proteasome inhibition suppresses dengue virus egress in antibody dependent infection","volume":"9","author":"Choy","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.coviro.2020.07.009_bib0620","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.virusres.2012.01.009","article-title":"A small-molecule inhibitor of deubiquitinating enzyme USP14 inhibits dengue virus replication","volume":"165","author":"Nag","year":"2012","journal-title":"Virus Res"},{"key":"10.1016\/j.coviro.2020.07.009_bib0625","doi-asserted-by":"crossref","first-page":"4960","DOI":"10.1021\/pr100219y","article-title":"The ubiquitin\u2212proteasome pathway is important for dengue virus infection in primary human endothelial cells","volume":"9","author":"Kanlaya","year":"2010","journal-title":"J Proteome Res"},{"key":"10.1016\/j.coviro.2020.07.009_bib0630","doi-asserted-by":"crossref","DOI":"10.3390\/v8020046","article-title":"Suppressive effects of the site 1 protease (S1p) inhibitor, PF-429242, on dengue virus propagation","volume":"8","author":"Uchida","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.coviro.2020.07.009_bib0635","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/rmv.483","article-title":"Mechanisms of action of ribavirin against distinct viruses","volume":"16","author":"Graci","year":"2006","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.coviro.2020.07.009_bib0640","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1128\/JVI.79.3.1943-1947.2005","article-title":"The Predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase","volume":"79","author":"Leyssen","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.07.009_bib0645","doi-asserted-by":"crossref","first-page":"35638","DOI":"10.1074\/jbc.M400460200","article-title":"A structural basis for the inhibition of the NS5 dengue virus mRNA 2\u2032-O-methyltransferase domain by ribavirin 5\u2032-triphosphate","volume":"279","author":"Benarroch","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coviro.2020.07.009_bib0650","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1099\/vir.0.81655-0","article-title":"Inhibition of dengue virus replication by mycophenolic acid and ribavirin","volume":"87","author":"Takhampunya","year":"2006","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coviro.2020.07.009_bib0655","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0162-3109(00)00188-0","article-title":"Mycophenolate mofetil and its mechanisms of action","volume":"47","author":"Allison","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.coviro.2020.07.009_bib0660","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.antiviral.2010.04.007","article-title":"A novel nucleoside analog, 1-\u03b2-d-ribofuranosyl-3-ethynyl-[1,2,4]triazole (ETAR), exhibits efficacy against a broad range of flaviviruses in vitro","volume":"87","author":"McDowell","year":"2010","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2020.07.009_bib0665","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12929-015-0134-2","article-title":"Antiviral activity of an N-allyl acridone against dengue virus","volume":"22","author":"Mazzucco","year":"2015","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.coviro.2020.07.009_bib0670","doi-asserted-by":"crossref","first-page":"6548","DOI":"10.1128\/JVI.02510-10","article-title":"Inhibition of dengue virus through suppression of host pyrimidine biosynthesis","volume":"85","author":"Wang","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.07.009_bib0675","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1128\/AAC.00561-10","article-title":"Characterization of dengue virus resistance to brequinar in cell culture","volume":"54","author":"Qing","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coviro.2020.07.009_bib0680","doi-asserted-by":"crossref","first-page":"5777","DOI":"10.1073\/pnas.1101143108","article-title":"Broad-spectrum antiviral that interferes with de novo pyrimidine biosynthesis","volume":"108","author":"Hoffmann","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2020.07.009_bib0685","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.antiviral.2014.03.014","article-title":"Amodiaquine, an antimalarial drug, inhibits dengue virus type 2 replication and infectivity HHS public access","volume":"106","author":"Boonyasuppayakorn","year":"2014","journal-title":"Antivir Res"},{"key":"10.1016\/j.coviro.2020.07.009_bib0690","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1016\/j.bmcl.2013.05.101","article-title":"Cyclophilin inhibitors as antiviral agents","volume":"23","author":"Peel","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.coviro.2020.07.009_bib0695","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1128\/AAC.00189-09","article-title":"Cyclosporine inhibits flavivirus replication through blocking the interaction between host cyclophilins and viral NS5 protein","volume":"53","author":"Qing","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coviro.2020.07.009_sbref0700","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1172\/JCI89857","article-title":"Anticancer kinase inhibitors impair intracellular viral trafficking and exert broad-spectrum antiviral effects","volume":"127","author":"Bekerman","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coviro.2020.07.009_bib0705","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.antiviral.2018.05.001","article-title":"Feasibility and biological rationale of repurposing sunitinib and erlotinib for dengue treatment","volume":"155","author":"Pu","year":"2018","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2020.07.009_bib0710","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1073\/pnas.0611681104","article-title":"c-Src protein kinase inhibitors block assembly and maturation of dengue virus","volume":"104","author":"Chu","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2020.07.009_bib0715","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023246","article-title":"The kinase inhibitor sfv785 dislocates dengue virus envelope protein from the replication complex and blocks virus assembly","volume":"6","author":"Anwar","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.coviro.2020.07.009_bib0720","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.antiviral.2014.08.004","article-title":"Modulation of inflammation and pathology during dengue virus infection by p38 MAPK inhibitor SB203580","volume":"110","author":"Fu","year":"2014","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2020.07.009_bib0725","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1128\/JVI.02309-14","article-title":"Dengue virus induces and requires glycolysis for optimal replication","volume":"89","author":"Fontaine","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.07.009_bib0730","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.chembiol.2016.03.010","article-title":"GNF-2 inhibits dengue virus by targeting Abl kinases and the viral e protein","volume":"23","author":"Clark","year":"2016","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.coviro.2020.07.009_bib0735","doi-asserted-by":"crossref","first-page":"8698","DOI":"10.1128\/JVI.79.14.8698-8706.2005","article-title":"Castanospermine, a potent inhibitor of dengue virus infection in vitro and in vivo","volume":"79","author":"Whitby","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.07.009_bib0740","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1128\/JVI.74.1.564-572.2000","article-title":"Alpha -glucosidase inhibitors reduce dengue virus production by affecting the initial steps of virion morphogenesis in the endoplasmic reticulum","volume":"74","author":"Courageot","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.07.009_bib0745","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.antiviral.2011.10.002","article-title":"Celgosivir treatment misfolds dengue virus NS1 protein, induces cellular pro-survival genes and protects against lethal challenge mouse model","volume":"92","author":"Rathore","year":"2011","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2020.07.009_bib0750","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.antiviral.2015.12.008","article-title":"Optimizing celgosivir therapy in mouse models of dengue virus infection of serotypes 1 and 2: the search for a window for potential therapeutic efficacy","volume":"127","author":"Watanabe","year":"2016","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2020.07.009_bib0755","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S1473-3099(14)70730-3","article-title":"Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial","volume":"14","author":"Low","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.coviro.2020.07.009_bib0760","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.4155\/fmc.11.117","article-title":"Iminosugars as therapeutic agents: recent advances and promising trends","volume":"3","author":"Nash","year":"2011","journal-title":"Future Med Chem"},{"key":"10.1016\/j.coviro.2020.07.009_bib0765","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1128\/JVI.76.8.3596-3604.2002","article-title":"Antiviral effects of an iminosugar derivative on flavivirus infections","volume":"76","author":"Wu","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.07.009_bib0770","doi-asserted-by":"crossref","first-page":"6379","DOI":"10.1128\/AAC.01554-12","article-title":"Liposome-mediated delivery of iminosugars enhances efficacy against dengue virus in vivo","volume":"56","author":"Miller","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coviro.2020.07.009_bib0775","unstructured":"Gu B, Mason P, Wang L, Norton P, Bourne N, Moriarty R, Mehta A, Despande M, Shah R, Block T: Antiviral profiles of novel iminocyclitol compounds against bovine viral diarrhea virus, West Nile virus, dengue virus and hepatitis B virus. [date unknown]."},{"key":"10.1016\/j.coviro.2020.07.009_bib0780","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1128\/AAC.01457-08","article-title":"Novel imino sugar derivatives demonstrate potent antiviral activity against flaviviruses","volume":"53","author":"Chang","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coviro.2020.07.009_bib0785","doi-asserted-by":"crossref","unstructured":"Yu W, Gill T, Wang L, Du Y, Ye H, Qu X, Guo J-T, Cuconati A, Zhao K, Block TM, et al.: Design, synthesis, and biological evaluation of N-alkylated deoxynojirimycin (DNJ) derivatives for the treatment of dengue virus infection. [date unknown], doi:https:\/\/doi.org\/10.1021\/jm300171v.","DOI":"10.1021\/jm300171v"},{"key":"10.1016\/j.coviro.2020.07.009_bib0790","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.antiviral.2013.01.004","article-title":"An iminosugar with potent inhibition of dengue virus infection in vivo","volume":"98","author":"Perry","year":"2013","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2020.07.009_bib0795","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.antiviral.2016.03.001","article-title":"Inhibition of endoplasmic reticulum glucosidases is required for in vitro and in vivo dengue antiviral activity by the iminosugar UV-4","volume":"129","author":"Warfield","year":"2016","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2020.07.009_bib0800","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.3390\/v7052404","article-title":"A novel iminosugar UV-12 with activity against the diverse viruses influenza and dengue (Novel iminosugar antiviral for influenza and dengue)","volume":"7","author":"Warfield","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.coviro.2020.07.009_bib0805","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.antiviral.2010.11.002","article-title":"Combination of \u03b1-glucosidase inhibitor and ribavirin for the treatment of dengue virus infection in vitro and in vivo","volume":"89","author":"Chang","year":"2011","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2020.07.009_bib0810","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.antiviral.2013.03.023","article-title":"Small molecule inhibitors of ER \u03b1-glucosidases are active against multiple hemorrhagic fever viruses","volume":"98","author":"Chang","year":"2013","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2020.07.009_bib0815","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ijantimicag.2012.05.002","article-title":"Antiviral activities of sulfonium-ion glucosidase inhibitors and 5-thiomannosylamine disaccharide derivatives against dengue virus","volume":"40","author":"Mohan","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.coviro.2020.07.009_bib0820","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/cbic.200500321","article-title":"Novel five-membered iminocyclitol derivatives as selective and potent glycosidase inhibitors: new structures for antivirals and osteoarthritis","volume":"7","author":"Liang","year":"2006","journal-title":"ChemBioChem"},{"key":"10.1016\/j.coviro.2020.07.009_bib0825","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1093\/cid\/cis655","article-title":"Effects of short-course oral corticosteroid therapy in early dengue infection in Vietnamese patients: a randomized, placebo-controlled trial","volume":"55","author":"Tam","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coviro.2020.07.009_bib0830","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1371\/journal.pntd.0002592","article-title":"Corticosteroids for dengue - why don\u2019t they work?","volume":"7","author":"Nguyen","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.coviro.2020.07.009_bib0835","first-page":"1397","article-title":"Effect of high dose of steroid on plateletcount in acute stage of dengue fever with thrombocytopenia","volume":"7","author":"Shashidhara","year":"2013","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/j.coviro.2020.07.009_bib0840","article-title":"Schisandrin A inhibits dengue viral replication via upregulating antiviral interferon responses through STAT signaling pathway","volume":"7","author":"Yu","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.coviro.2020.07.009_bib0845","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.antiviral.2016.11.010","article-title":"Celastrol inhibits dengue virus replication via up-regulating type I interferon and downstream interferon-stimulated responses","volume":"137","author":"Yu","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2020.07.009_bib0850","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1007\/s00705-016-3034-1","article-title":"Salidroside exhibits anti-dengue virus activity by upregulating host innate immune factors","volume":"161","author":"Sharma","year":"2016","journal-title":"Arch Virol"},{"key":"10.1016\/j.coviro.2020.07.009_bib0855","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/jir.2014.0038","article-title":"Hydroxychloroquine-inhibited dengue virus is associated with host defense machinery","volume":"35","author":"Wang","year":"2015","journal-title":"J Interf Cytokine Res"},{"key":"10.1016\/j.coviro.2020.07.009_bib0860","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2017.00668","article-title":"Asunaprevir evokes hepatocytes innate immunity to restrict the replication of hepatitis C and dengue virus","volume":"8","author":"Tsai","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.coviro.2020.07.009_bib0865","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1590\/0074-02760160323","article-title":"Decrease in dengue virus-2 infection and reduction of cytokine\/chemokine production by Uncaria guianensis in human hepatocyte cell line huh-7","volume":"112","author":"Da Silva Mello","year":"2017","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.coviro.2020.07.009_bib0870","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.intimp.2007.11.010","article-title":"Immunomodulating and antiviral activities of Uncaria tomentosa on human monocytes infected with dengue virus-2","volume":"8","author":"Reis","year":"2008","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.coviro.2020.07.009_bib0875","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.bbrc.2016.07.029","article-title":"Drug repurposing of minocycline against dengue virus infection","volume":"478","author":"Leela","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.coviro.2020.07.009_bib0880","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.antiviral.2014.09.004","article-title":"MEK\/ERK activation plays a decisive role in yellow fever virus replication: Implication as an antiviral therapeutic target","volume":"111","author":"Albarnaz","year":"2014","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2020.07.009_bib0885","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.celrep.2017.03.071","article-title":"The natural product cavinafungin selectively interferes with zika and dengue virus replication by inhibition of the host signal peptidase","volume":"19","author":"Estoppey","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.coviro.2020.07.009_bib0890","doi-asserted-by":"crossref","first-page":"5388","DOI":"10.1073\/pnas.1522987113","article-title":"Human DDX3 protein is a valuable target to develop broad spectrum antiviral agents","volume":"113","author":"Brai","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2020.07.009_bib0895","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.antiviral.2014.09.007","article-title":"Antiviral activity of lanatoside C against dengue virus infection","volume":"111","author":"Cheung","year":"2014","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2020.07.009_bib0900","doi-asserted-by":"crossref","first-page":"15589","DOI":"10.1074\/jbc.M808271200","article-title":"CRM1-mediated nuclear export of dengue virus RNA polymerase NS5 modulates interleukin-8 induction and virus production","volume":"284","author":"Rawlinson","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coviro.2020.07.009_bib0905","doi-asserted-by":"crossref","first-page":"5315","DOI":"10.1016\/j.bmc.2014.07.051","article-title":"The enantiomers of the 1\u2032,6\u2032-isomer of neplanocin A: synthesis and antiviral properties","volume":"22","author":"Ye","year":"2014","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.coviro.2020.07.009_bib0910","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.antiviral.2009.02.204","article-title":"Antiviral activity of geneticin against dengue virus","volume":"83","author":"Zhang","year":"2009","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2020.07.009_bib0915","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.antiviral.2016.02.005","article-title":"Lactimidomycin is a broad-spectrum inhibitor of dengue and other RNA viruses HHS public access","volume":"128","author":"Carocci","year":"2013","journal-title":"Antivir Res"},{"key":"10.1016\/j.coviro.2020.07.009_bib0920","first-page":"1","article-title":"Influence of mast cells on dengue protective immunity and immune pathology","volume":"9","author":"John","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2020.07.009_bib0925","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004965","article-title":"DenHunt-a comprehensive database of the intricate network of dengue-human interactions","volume":"10","author":"Karyala","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.coviro.2020.07.009_sbref0930","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005879","article-title":"DenvInt: a database of protein\u2013protein interactions between dengue virus and its hosts","volume":"11","author":"Dey","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.coviro.2020.07.009_bib0935","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1128\/CMR.00035-09","article-title":"Dengue virus pathogenesis: an integrated view","volume":"22","author":"Martina","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.coviro.2020.07.009_sbref0940","first-page":"1","article-title":"3D miniaturization of human organs for drug discovery","volume":"7","author":"Park","year":"2018","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.coviro.2020.07.009_sbref0945","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-63397-7","article-title":"Tomatidine, a natural steroidal alkaloid shows antiviral activity towards chikungunya virus in vitro","volume":"10","author":"Troost","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.coviro.2020.07.009_bib0950","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev-pharmtox-010715-103715","article-title":"The cellular thermal shift assay: a novel biophysical assay for in situ drug target engagement and mechanistic biomarker studies","volume":"56","author":"Martinez Molina","year":"2016","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.coviro.2020.07.009_bib0955","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1233606","article-title":"Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay","volume":"341","author":"Molina","year":"2013","journal-title":"Science (80-)"},{"key":"10.1016\/j.coviro.2020.07.009_bib0960","series-title":"In Vitro and In Vivo Assessment of ADME and PK Properties During Lead Selection and Lead Optimization \u2013 Guidelines, Benchmarks and Rules of Thumb","author":"Chung","year":"2015"},{"key":"10.1016\/j.coviro.2020.07.009_bib0965","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.antiviral.2015.08.013","article-title":"Animal models for studying dengue pathogenesis and therapy","volume":"123","author":"Chan","year":"2015","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2020.07.009_sbref0970","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1021\/acsinfecdis.8b00054","article-title":"Preclinical antiviral testing for dengue virus infection in mouse models and its association with clinical studies","volume":"4","author":"Watanabe","year":"2018","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.coviro.2020.07.009_sbref0975","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-22618-w","article-title":"Characterization of a murine model of non-lethal, symptomatic dengue virus infection","volume":"8","author":"Sarathy","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.coviro.2020.07.009_bib0980","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1128\/AAC.00620-11","article-title":"A translation inhibitor that suppresses dengue virus in vitro and in vivo","volume":"55","author":"Wang","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coviro.2020.07.009_bib0985","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.crad.2015.03.010","article-title":"FDG PET\/CT in infection and inflammation - current and emerging clinical applications","volume":"70","author":"Vaidyanathan","year":"2015","journal-title":"Clin Radiol"},{"key":"10.1016\/j.coviro.2020.07.009_bib0990","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.93474","article-title":"18F-FDG as an inflammation biomarker for imaging dengue virus infection and treatment response","volume":"2","author":"Chacko","year":"2017","journal-title":"JCI insight"},{"key":"10.1016\/j.coviro.2020.07.009_bib0995","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/CMR.00102-15","article-title":"Approved antiviral drugs over the past 50 years","volume":"29","author":"De Clercq","year":"2016","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.coviro.2020.07.009_bib1000","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1128\/AAC.04779-14","article-title":"Synergistic suppression of dengue virus replication using a combination of nucleoside analogs and nucleoside synthesis inhibitors","volume":"59","author":"Yeo","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coviro.2020.07.009_bib1005","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.antiviral.2017.02.014","article-title":"Current therapy for chronic hepatitis C: the role of direct-acting antivirals","volume":"142","author":"Li","year":"2017","journal-title":"Antiviral Res"}],"container-title":["Current Opinion in Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625720300523?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625720300523?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:03:31Z","timestamp":1761818611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879625720300523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":201,"alternative-id":["S1879625720300523"],"URL":"https:\/\/doi.org\/10.1016\/j.coviro.2020.07.009","relation":{},"ISSN":["1879-6257"],"issn-type":[{"value":"1879-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances in antiviral drug development towards dengue virus","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coviro.2020.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}